⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DAWN News
Day One Biopharmaceuticals, Inc. Common Stock
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
DAWN
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
globenewswire.com
DAWN
Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
globenewswire.com
DAWN
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
globenewswire.com
DAWN